ReviewAsian journal of pharmaceutical sciences2022

Delivery strategies for CRISPR/Cas genome editing tool for retinal dystrophies: challenges and opportunities.

Aayushi Lohia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.